Brain and spinal cord distribution of biphalin: Correlation with opioid receptor density and mechanism of CNS entry

Journal of Neurochemistry

Volumn 69, Issue 3, 1997, Pages 1236-1245

  Abbruscato, Thomas J ^a   Thomas, Sarah A ^a   Hruby, Victor J ^b   Davis, Thomas P ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b University of Arizona   (United States)

Author keywords

Biphalin; Blood brain barrier; Cerebrospinal fluid; Kinetics; Opioid; Saturation; Spinal cord; Transport

Indexed keywords

BIPHALIN; ETORPHINE; MORPHINE; OPIATE RECEPTOR;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; DRUG POTENCY; DRUG RECEPTOR BINDING; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LIPOPHILICITY; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 0030742898     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69031236.x     Document Type: Article

References (42)

1. Abbruscato T. J., Williams S. A., Misicka A., Lipkowski A. W., Hruby V. J., and Davis T. P. (1996) Blood-to-CNS entry and stability of biphalin, a unique double-enkephalin analog, and its halogenated derivatives. J. Pharmacol. Exp. Ther. 276, 1049-1057.
2. Abbruscato T. J., Thomas S. A., Hruby V. J., and Davis T. P. (1997) Blood-brain barrier permeability and bioavailability of a highly potent and mu-selective opioid receptor antagonist, CTAP: comparison with morphine. J. Pharmacol. Exp. Ther. 280, 402-409.
3. Ayres E. A., Davis P., and Burks T. F. (1990) In vivo and in vitro investigation of naltrindole, a delta-opioid antagonist. Proc. West. Pharmacol. Soc. 33, 55-63.
4. Banks W. A. and Kastin A. J. (1994) Opposite direction of transport across the blood-brain barrier for Tyr-MIF-1 and MIF-1: comparison with morphine. Peptides 15, 23-29.
5. Bolton A. E. (1986) Comparative methods for the radiolabeling of peptides. Methods Enzymol. 124, 18-29.
6. Brownson E. A., Abbruscato T. J., Gillespie T. J., Hruby V. J., and Davis T. P. (1994) Effect of peptidases at the BBB on the permeability of enkephalin. J. Pharmacol. Exp. Ther. 270, 675-680.
7. Bzdega T., Chin H., Kim H., Jung H. H., Kozak C. A., and Klee W. A. (1993) Regional expression and chromosomal localization of the delta opiate receptor gene. Proc. Natl. Acad. Sci. USA 90, 9305-9309.
8. Chikhale E. G., Chikhale P. J., and Borchardt R. T. (1995) Carrier-mediated transport of the antitumor agent acivicin across the blood-brain barrier. Biochem. Pharmacol. 49, 941-945.
9. Craigie E. H. (1919) On the relative vascularity of various parts of the central nervous system of the albino rat. J. Comp. Neurol. 31, 429-464.
10. Daniel P. M., Lam D. K. C., and Pratt O. E. (1985) Comparison of the vascular permeability of the brain and the spinal cord to mannitol and inulin in the rats. J. Neurochem. 45, 647-649.
11. Davson H., Kleeman C. R., and Levin E. (1961) Blood-brain barrier and extracellular space. J. Physiol. (Lond.) 159, 67-68.
12. Erchegyi J., Kastin A. J., Zadina J. E., and Qiu X.-D. (1991) Isolation of a heptapeptide Val-Val-Tyr-Pro-Trp-Thr-Gln (valorphin) and some opiate activity. Int. J. Pept. Protein Res. 39, 477-488.
13. Gjedde A. (1983) Modulation of substrate transport to the brain. Acta Neurol. Scand. 67, 3-25.
14. Gjedde A. (1988) Exchange diffusion of large neutral amino acids between blood and brain, in Peptide and Amino Acids Transport Mechanisms in the Central Nervous System (Rakic L., Begley D. J., Davson H., and Zlokovic B. V., eds), pp. 209-217. Macmillan Press, London.
15. Hargreaves K. M. and Pardridge W. M. (1988) Neutral amino acid transport at the human blood-brain barrier. J. Biol. Chem. 236, 19392-19397.
16. Horan P. J., Mattie A., Bilsky E. J., Weber S. J., Davis T. P., Yamamura H. I., Matynska E., Appleyard S. M., Slaninova J., Misicka A., Lipkowski A. W., Hruby V. J., and Porreca F. (1993) Antinociceptive profile of biphalin, a dimeric enkephalin analog. J. Pharmacol. Exp. Ther. 265, 1446-1454.
17. Joó F., Lengyel I., Kovacs J., and Penke B. (1992) Regulation of transendothelial transport in the cerebral microvessels: the role of second messenger-generating systems. Prog. Brain Res. 91, 177-187.
18. Lipkowski A. W., Konecka A. M., and Scoczynska I. (1982) Double-enkephalins - synthesis, activity on guinea-pig ileum, and analgesic effect. Peptides 3, 697-700.
19. Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
20. Mansour A., Fox C. A., Akil H., and Watson S. J. (1995) Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18, 22-29.
21. Misicka A., Lipkowski A. W., Horvath R., Davis P., Porreca F., Yamamura H. I., and Hruby V. J. (1997) Structure activity relationships of biphalin. The synthesis and biological activities of new analogs with modifications in position 3 and 4. Life Sci. 60, 1263-1269.
22. Oldendorf W. H. (1971) Brain uptake of radiolabeled amino acids, amines and hexoses after arterial injection. Am. J. Physiol. 221, 1629-1639.
23. Oldendorf W. H. and Szabo J. (1976) Amino acid assignment to one of three blood-brain barrier amino acid carriers. Am. J. Physiol. 230, 94-98.
24. Paulus H. (1969) A rapid and sensitive method for measuring the binding of radioactive ligands to proteins. Anal. Biochem. 32, 91-100.
25. Portoghese P. S., Sultana M., and Takemori A. E. (1988) Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist. Eur. J. Pharmacol. 146, 185-186.
26. 14C]-carboxylinulin across the blood-brain barrier and blood-spinal cord barrier in the rabbit. J. Spinal Cord Med. 18, 221-226.
27. Sharif N. A. and Hughes J. (1989) Discrete mapping of brain mu and delta opioid receptors using selective peptides: quantitative autoradiography, species differences and comparison with kappa receptors. Peptides 10, 499-522.
28. Silbert B. S., Lipkowski A. W., Cepeda M. S., Szyfelbein S. K., Osgood P. F., and Carr D. B. (1991) Analgesic activity of a novel bivalent opioid peptide compared to morphine via different routes of administration. Agents Actions 33, 382-387.
29. Smith Q. R., Takasato Y., and Rapoport S. I. (1984) Kinetic analysis of L-leucine transport across the blood-brain barrier. Brain Res. 311, 167-170.
30. Stevens C. W. (1994) Perspectives on opioid tolerance from basic research: behavioral studies after spinal administration in rodents. Cancer Surv. 21, 25-47.
31. Stevens C. W. and Yaksh T. L. (1989) Magnitude of opioid dependence after continuous intrathecal infusion of mu- and delta-selective opioids in the rat. Eur. J. Pharmacol. 166, 467-472.
32. Takada Y., Greig N. H., Vistica D. T., Rapoport S. I., and Smith Q. R. (1991) Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrier. Cancer Chemother. Pharmacol. 29, 89-94.
33. Takasato Y., Momma S., and Smith Q. R. (1985) Kinetic analysis of cerebrovascular isoleucine transport from saline and plasma. J. Neurochem. 45, 1013-1020.
34. Toth G., Kramer T. H., Knapp R., Lui G., Davis P., Burks T. F., Yamamura H. I., and Hruby V. J. (1990) DPDPE analogues with increased affinity and selectivity of delta opioid receptors. J. Med. Chem. 33, 249-253.
35. Wang Z., Bilsky E. J., Porreca F., and Sadee W. (1994) Constitutive mu opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence. Life Sci. 54, PL339-PL350.
36. 5] enkephalin and two halogenated analogs after intravenous administration. J. Pharmacol. Exp. Ther. 259, 1109-1117.
37. 5] enkephalin opioid analogs. J. Pharmacol Exp. Ther. 266, 1649-1655.
38. 2,5] enkephalin, across the blood-brain and blood-cerebrospinal fluid barriers. J. Neurochem. 66, 1289-1299.
39. Zloković B. V. (1995) Cerebrovascular permeability to peptides: manipulations of transport systems at the blood-brain barrier. Pharmacol. Res. 12, 1395-1406.
40. Zloković B. V., Begley D. J., Djuričić B. M., and Mitrovic D. M. (1986) Measurement of solute transport across the blood-brain barrier in the perfused guinea pig brain: method and application to N-methyl-α-aminoisobutyric acid. J. Neurochem. 46, 1444-1451.
41. Zloković B. V., Mackic J. B., Djuricic B. M., and Davson H. (1989) Kinetic analysis of leucine-enkephalin cellular uptake at the luminal side of the blood-brain barrier of an in situ perfused guinea-pig brain. J. Neurochem. 53, 1333-1340.
42. Zloković B. V., Hyman S., McComb J. G., Lipovac M. N., Tang G., and Davson H. (1990) Kinetics of arginine-vasopressin uptake at the blood-brain barrier. Biochim. Biophys. Acta 1025, 191-198.